LFLucy Findlater

Lucy Findlater

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lucy Findlater has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A multi-country outbreak of Salmonella Blockley associated with tomato consumption, July to October 2024

    by Ann Hoban, Lucy Findlater, Ellen Heinsbroek, Juliette Cavaye, Anais Painset, Clare Maguire, Katie Thorley, Andrew Nelson, Lynda Browning, Derek Brown, et al.

    Between July and October 2024, 216 cases with genetically related Salmonella Blockley sequence type 52 were identified in France (n = 56), Germany (n = 30), the United Kingdom (UK) (n = 129) and the United States (US) (n = 1). Case interviews in the UK identified tomatoes as a possible vehicle of infection. A rapid case–control study with 29 cases and 87 controls was conducted to investigate this hypothesis, using pre-existing control data. Multivariable, Firth penalised logistic regression was used to explore associations between illness, food exposures and retailers. Consumption of tomatoes and shopping at Retailer A (adjusted odds ratio (aOR) = 10.75; 95% confidence interval (CI): 1.52–103.16) was associated with being a case. Salmonella spp. was not detected in any of the 312 tomato samples tested by a standard culture method, but a low concentration of Salmonella DNA was detected in two enriched broths by PCR. These detections could not be confirmed by culture. Evidence derived from epidemiological, microbiological and food chain investigations in the UK identified imported tomatoes from Morocco as the most likely vehicle of infection.

  • Response to Skally et al.Journal of Hospital Infection, 15/05/2026

    by Lucy Findlater, Emily L. Mason, Jacquelyn McCormick, Colin S. Brown, Katie L. Hopkins, Jasmin Islam, Victoria J. Hall, Katherine L. Henderson

  • Open Access

    Investigation of an ongoing cluster of tuberculosis (TB) associated with prisons, England

    by Lucy Findlater, Mailis Maes, Nathan Post, Amith Philip, Lauren Ahyow, Chantal Edge, Martin Dedicoat, Tracey Langham, Suzi Coles, Esther Robinson

    Prisons are high-risk environments for the spread of tuberculosis (TB). We investigated an ongoing prison-associated TB cluster to identify common exposures. We defined cases as residents in England with laboratory-confirmed TB belonging to the genetic cluster. We extracted records from the National TB Surveillance System, linked to prison operational data, and conducted descriptive analysis of demographic, clinical, and phylogenetic data. Years were masked for anonymity. Over six years, 12 individuals were identified, predominantly male (83%) and median age 34 years, in London, East Midlands, and East of England. Prison history was noted for 7/12 (58%) at 13 prisons. Everyone without prison history completed treatment, but 2/7 with prison history were lost to follow-up and 5/7 were still in treatment or outcome not evaluated. We identified frequent prison transfers and concurrent stays of four individuals at Prison B, and two at Prison G. Phylogenetic analysis indicated distinct sub-clusters with and without prison history, suggesting expansion of the cluster from community into prisons. Prisons continue to play a role in TB in England. Factors such as frequency of transfers could hinder treatment completion and control of transmission. Combining phylogenetic, epidemiological, and prison operational data facilitated investigation of transmission pathways.

  • Open Access

    Frequency of bacterial STI testing amongst people accessing sexual health services in England, 2024: a cross-sectional analysis of national surveillance data

    by George Baldry, Ana-Karina Harb, Lucy Findlater, Dana Ogaz, Stephanie J Migchelsen, Helen Fifer, John Saunders, Hamish Mohammed, Katy Sinka

    Objectives We determined the frequency of sexually transmitted infection (STI) testing among people accessing sexual health services (SHS) in England. Methods We assessed STI testing frequency in face-to-face and online SHSs in England using data from the GUMCAD STI surveillance system. We quantified different combinations of tests (e.g. single chlamydia test or full STI screen), number of tests completed in 2024 and test positivity by sociodemographic and behavioural characteristics, as well as clinical setting and outcomes. Results Overall, there were 2,222,028 attendances at SHS in England in 2024 that involved tests for chlamydia, gonorrhoea, syphilis and/or HIV. Most of these attendances involved tests for all four of these STIs. Most people accessing SHS in England tested once (80.1%), and a small minority (1.9%) tested at least quarterly (4+ times). Some groups had a comparably larger proportion of quarterly testers; these included gay, bisexual, and other men who have sex with men (GBMSM) (6.7%), London residents (3.6%), online testers (2.5%), people using HIV-PrEP (13%), and people with 5+ partners in the previous 3 months (10.6%). Only 10.5% of GBMSM reporting higher-risk sexual behaviours tested quarterly despite recommendations for quarterly testing in this group. Conclusions The majority of those who tested for STIs in England in 2024 only tested once. The minority who tested at least quarterly had a higher proportion of GBMSM, people using HIV-PrEP, London residents and people reporting higher risk behaviours. Quarterly testing often appears to be aligned with current testing recommendations in England; however, we also observed that only a low proportion of behaviourally high-risk GBMSM and HIV-PrEP users are meeting these recommendations. It is important to acknowledge groups with lower or higher testing frequency when developing interventions and updating guidelines related to STI testing.

  • Open Access

    Characteristics associated with frequent sexually transmitted infection (STI) testing in a community-based sample of gay, bisexual, and other men who have sex with men (GBMSM), United Kingdom, 2024

    by Lucy Findlater, George Baldry, Ana K. Harb, Dolores Mullen, Dawn Phillips, Erna Buitendam, Catherine M. Lowndes, David Reid, Catherine H. Mercer, John Saunders, et al.

    In the UK, gay, bisexual, and other men who have sex with men (GBMSM) at risk of sexually transmitted infections (STIs) are recommended quarterly testing, but it is not known how many are following this recommendation. We described prevalence and correlates of frequent STI testing amongst GBMSM. We analysed data from the community-based Reducing Inequalities in Sexual Health (RiiSH) online survey of GBMSM, with recruitment in November-December 2024 via social media and dating apps. Participants were UK residents aged ≥16 years reporting sex with a man in the previous year. We described frequency of STI testing amongst individuals recommended quarterly testing, using proxies for national guidelines for quarterly testing eligibility (over the past three months: new male sexual partner, condomless anal sex, ≥ 10 male partners, or chemsex). We explored factors associated with frequent testing (≥4 tests/past year) using univariate and multivariable logistic regression, adjusting for country of birth and residence, ethnicity, employment, and education. Among 2758 participants (median age 45 years, 88% white), we estimated 2366 (86%) would be recommended quarterly STI testing. Among 2342 with testing information, 562 individuals (24%) met or exceeded this recommendation (≥4 tests), 1107 (47%) had 1–3 tests, and 673 (29%) none. Factors associated with frequent testing were: reporting using HIV-PrEP in the past year (adjusted odds ratio 7.66 (95% confidence intervals 5.77-10.30)), STI diagnosis in the past three months (1.96 (1.45-2.64)), and younger age (1.50 (1.04-2.16), 16–29 years vs ≥ 45 years). Straight/bisexual orientation was associated with less frequent testing than gay/homosexual (0.71 (0.52-0.96)). Overall, data from a large UK community survey suggest only 1 in 4 GBMSM who are recommended quarterly STI testing meet this recommendation, and testing levels vary by HIV-PrEP use, STI history, age, and sexual orientation. These findings provide baseline data for consideration in any updates to STI testing guidelines.


  • Open Access

    High morbidity and mortality in children with invasive lower respiratory tract group A streptococcal infection in England, winter 2022

    by Katie Wrenn, Paula B. Blomquist, Carmellie Inzoungou-Massanga, Rebecca L. Guy, Oluwakemi Olufon, Diane Hatziioanou, Lucy Findlater, Iona Smith, Karen Luyt, Tom Williams, et al.


  • Open Access

    Is mandatory surveillance of carbapenemase-producing Gram-negative organisms working? A surveillance evaluation, England, 2020–2023

    by L. Findlater, E.L. Mason, J. McCormick, C.S. Brown, J. Islam, V.J. Hall, K.L. Henderson


  • Open Access

    Characteristics associated with frequent sexually transmitted infection (STI) testing in a community-based sample of gay, bisexual, and other men who have sex with men (GBMSM), United Kingdom, 2024

    by Lucy Findlater, George Baldry, Ana K. Harb, Dolores Mullen, Dawn Phillips, Erna Buitendam, Catherine M. Lowndes, David Reid, Catherine H. Mercer, John Saunders, et al.

    In the UK, gay, bisexual, and other men who have sex with men (GBMSM) at risk of sexually transmitted infections (STIs) are recommended quarterly testing, but it is not known how many are following this recommendation. We described the prevalence and correlates of frequent STI testing amongst GBMSM. We analysed data on participants of the community-based Reducing Inequalities in Sexual Health (RiiSH) online survey of GBMSM, recruited in November-December 2024 via social media and dating apps. Participants were UK residents aged ≥16 years who reported sex with a man in the previous year. We described the frequency of STI testing amongst individuals recommended quarterly testing, using proxies for national guidelines for quarterly testing eligibility (over the past three months: new male sexual partner, condomless anal sex, ≥10 male partners, or chemsex). We explored factors associated with frequent testing (≥4 tests/past year) using univariate and multivariable logistic regression, adjusting for country of birth and residence, ethnicity, employment, and education. Among 2758 participants (median age 45 years, 88% white), we estimated that 2366 (86%) would be recommended quarterly STI testing. Over the past year, 562 individuals (24%) met or exceeded this recommendation (testing ≥4 times), 1107 (47%) had 1-3 tests, and 673 (28%) no tests. Factors associated with frequent testing were: reporting using PrEP in the past year (adjusted odds ratio 7.66 (95% confidence intervals 5.77-10.30)), STI diagnosis in the past three months (1.96 (1.45-2.64)), and younger age (1.50 (1.04-2.16), aged 16-29 years vs ≥45 years). Straight/bisexual orientation was associated with less frequent testing than gay/homosexual (0.71 (0.52-0.96)). Overall, data from a large UK community survey suggest that only 1 in 4 GBMSM who are recommended frequent STI testing meet this recommendation, and testing levels vary by PrEP use, STI history, age, and sexual orientation. Interventions are needed to address these inequalities.

  • Open Access

    Increased detection of Shiga toxin-producing Escherichia coli (STEC) O26: environmental exposures and clinical outcomes, England, 2014-2023

    by Lucy Findlater, Orlagh Quinn, Amy Douglas, Clare Sawyer, Victoria J Hall, Claire Jenkins, Sooria Balasegaram

    In England, Shiga toxin-producing Escherichia coli (STEC) serogroup O26 has recently emerged as a public health concern, despite fewer than half of diagnostic laboratories in England having the capability to detect non-O157 STEC. STEC O26 cases frequently report exposure to farms or nurseries. We describe the epidemiology of STEC O26 and examine evidence for a relationship between O26 and exposure to these settings. We analysed national surveillance data describing laboratory-confirmed STEC cases and public health incidents over the past 10 years to explore the incidence, clinical outcomes, and association with farms and nurseries for STEC O26 cases compared to STEC O157 and other serogroups. Between 2014 and 2023, the proportion of STEC notifications which were STEC O26 increased from 2% (19/956) to 12% (234/1946). After adjusting for age, we found no difference in the likelihood of farm or nursery attendance between O26 and O157 cases but a significantly higher risk of HUS in O26 (adjusted risk ratio 3.13 (2.18-4.51)). We demonstrate that STEC O26 is associated with the same risk of farm or nursery attendance as other STEC serogroups but a higher risk of severe morbidity. Our findings reinforce the need for improved surveillance of non-O157 STEC.

  • Open Access

    Evaluating the impact on health outcomes of an event that resulted in a delay in contact tracing of COVID-19 cases in England, September 2020: an observational study

    by Lucy Findlater, Livia Pierotti, Charlie Turner, Adrian Wensley, Cong Chen, Shaun Seaman, Pantelis Samartsidis, Andre Charlett, Charlotte Anderson, Gareth Hughes, et al.

    Objective In September 2020, 15 861 SARS-CoV-2 case records failed to upload from the Second Generation Surveillance System (SGSS) to the Contact Tracing Advisory Service (CTAS) tool, delaying the contact tracing of these cases. This study used CTAS data to determine the impact of this delay on population health outcomes: transmission events, hospitalisations and mortality. Previously, a modelling study suggested a substantial impact. Design Observational study. Setting England. Population Individuals testing positive for SARS-CoV-2 and their reported contacts. Main outcome measures Secondary attack rates (SARs), hospitalisations and deaths among primary and secondary contacts were calculated, compared with all other concurrent, unaffected cases. Affected SGSS records were matched to CTAS records. Successive contacts and cases were identified and matched to hospital episode and mortality outcomes. Results Initiation of contact tracing was delayed by 3 days on average in the primary cases in the delay group (6 days) compared with the control group (3 days). This was associated with lower completion of contact tracing: 80% (95% CI: 79% to 81%) in delay group and 83% (95% CI: 83% to 84%) in control group. There was some evidence to suggest increased transmission to non-household contacts among those affected by the delay. The SAR for non-household contacts was higher among secondary contacts in the delay group than the control group (delay group: 7.9%, 95% CI: 6.5% to 9.2%; control group: 5.9%, 95% CI: 5.3% to 6.6%). There did not appear to be a significant difference between the delay and control groups in the odds of hospitalisation (crude OR: 1.1 (95% CI: 0.9 to 1.2)) or death (crude OR: 0.7 (95% CI: 0.1 to 4.0)) among secondary contacts. Conclusions Our analysis suggests that the delay in contact tracing had a limited impact on population health outcomes; however, contact tracing was not completed for all individuals, so some transmission events might not be captured.